Table of Contents
Chromatography Research International
Volume 2014 (2014), Article ID 628319, 7 pages
http://dx.doi.org/10.1155/2014/628319
Research Article

A Validated Stability Indicating RP-HPLC Method Development and Validation for Simultaneous Estimation of Aliskiren Hemifumarate and Amlodipine Besylate in Pharmaceutical Dosage Form

1Department of Pharmaceutical Chemistry, Joginpally B.R Pharmacy College, Moinabad, Ranga Reddy District, Telangana, India
2Aizant Drug Research Solutions, Hyderabad, Telangana, India
3Department of Pharmacology, Bhaskar Pharmacy College, Moinabad, Ranga Reddy District, Telangana, India

Received 13 August 2014; Revised 13 November 2014; Accepted 14 November 2014; Published 7 December 2014

Academic Editor: Kanji Miyabe

Copyright © 2014 Chinnalalaiah Runja et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. Wal, A. Wal, A. Rai, and A. Dixit, “Aliskiren: an orally active renin inhibitor,” Journal of Pharmacy and Bioallied Sciences, vol. 3, no. 2, pp. 189–193, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. W. M. Cheng, “Aliskiren: renin inhibitor for hypertension management,” Clinical Therapeutics, vol. 30, no. 1, pp. 31–47, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. J. M. Wood, C. R. Schnell, F. Cumin, J. Menard, and R. L. Webb, “Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats,” Journal of Hypertension, vol. 23, no. 2, pp. 417–426, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. The Merck Index, Monographs no. 3521, 3535, Merck & Co., 14th edition, 2006.
  5. K. K. Daugherty, “Aliskiren,” American Journal of Health-System Pharmacy, vol. 65, no. 14, pp. 1323–1332, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Vaidyanathan, V. Jarugula, H. A. Dieterich, D. Howard, and W. P. Dole, “Clinical pharmacokinetics and pharmacodynamics of aliskiren,” Clinical Pharmacokinetics, vol. 47, no. 8, pp. 515–531, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Tabassum, “Aliskiren: a new renin inhibitor as anti-hypertensive,” Journal of Applied Pharmaceutical Science, vol. 1, no. 3, pp. 30–33, 2011. View at Google Scholar · View at Scopus
  8. T. Ishimitsu, J. Minami, Y. Kawano, A. Numabe, S. Takishita, and H. Matsuoka, “Amlodipine, a long-acting calcium channel blocker, attenuates morning blood pressure rise in hypertensive patients,” Clinical and Experimental Pharmacology and Physiology, vol. 26, no. 7, pp. 500–504, 1999. View at Publisher · View at Google Scholar · View at Scopus
  9. J. E. Arrowsmith, S. F. Campbell, P. E. Cross et al., “Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents,” Journal of Medicinal Chemistry, vol. 29, no. 9, pp. 1696–1702, 1986. View at Publisher · View at Google Scholar · View at Scopus
  10. The Merck Index: An Encyclopedia of Chemicals, Drugs and Biologicals, Merck & Company, White House Station, NJ, USA, 13th edition, 2001.
  11. M. Wrasse-Sangoi, M. S. Sangoi, P. R. Oliveira, L. T. Secretti, and C. M. B. Rolim, “Determination of aliskiren in tablet dosage forms by a validated stability-indicating RP-LC method,” Journal of Chromatographic Science, vol. 49, no. 2, pp. 170–175, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. B. V. Venkata Raveendra, K. S. Pankaj, and I. Singhvi, “A validated RP-HPLC method for determination of Aliskiren And Amlodipine in tablet dosage form,” International Journal of Pharmacy, vol. 3, no. 3, pp. 601–606, 2013. View at Google Scholar
  13. P. Das, S. Patel, P. P. Radhika, E. V. S. Subramanyam, and A. Sharbaraya, “Simultaneous estimation of aliskiren and amlodipine in tablet dosage form by UV spectroscopy,” International Journal of Drug Development and Research, vol. 4, no. 2, pp. 265–270, 2012. View at Google Scholar · View at Scopus
  14. P. Samixa Rameshbhai and P. Chhaganbhai Nanjibhai, “Development and validation of absorbance correction method for simultaneous estimation of aliskiren and amlodipine in combined dosage form,” Asian Journal of Pharmaceutical Research and Health Care, vol. 5, no. 2, pp. 43–51, 2013. View at Google Scholar · View at Scopus
  15. “ICH stability testing of new drug substances and products Q1A (R2),” in Proceedings of International Conference on Harmonization, 2003.
  16. ICH Q2 (R1), “Validation of analytical procedures: text and methodology,” in Proceedings of the International Conference on Harmonization, pp. 1–13, Geneva, Switzerland, 2005.